Filtered By:
Condition: Atrial Fibrillation
Countries: Guatemala Health
This page shows you your search results in order of relevance.
Order by Relevance | Date
Total 1 results found since Jan 2013.
Cost Effectiveness Analysis Of Apixaban Compared To Oral Anticoagulants In The Prevention Of Thromboembolic Events In Patients With Non-Valvular Atrial Fibrillation In Guatemala In 2014
Atrial fibrillation (AF) is associated with development of thromboembolic events [1]. The standard therapy used in patients with non-valvular atrial fibrillation (NVAF) with risk of stroke is Warfarin. There are new oral anticoagulants (NOACs) that also are recommended [2].
Source: Value in Health - May 1, 2015 Category: Global & Universal Authors: M. Garita-Aguilar, M. Peralta-Acon, L. Jiménez-Crespo Source Type: research
